Companies → Alexion Pharmaceuticals, Inc.
Save to list
Remove

Alexion Pharmaceuticals, Inc.

United States, Massachusetts, Boston
Updated Jul 18, 2024 10:29
Description
AstraZeneca Rare Disease, known as Alexion, is a division of AstraZeneca that specializes in rare diseases. It was established after AstraZeneca acquired Alexion Pharmaceuticals, Inc. in 2021. For almost 30 years, Alexion has been at the forefront of rare disease research, with a mission to support patients and families suffering from these conditions by discovering, developing, and selling life-changing drugs. Alexion concentrates its research on innovative molecules and targets in the complement cascade, while its development work focuses on haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. With offices worldwide, Alexion is headquartered in Boston, Massachusetts, and serves patients in more than 50 countries.
Disclaimer:
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.